PPARD and endothelial dysfunction: Ali et al. showed for the first time in vivo that PPARδ ligands induce vascular endothelial HO-1 expression, thus supporting the hypothesis that PPARδ represents an important potential target for the treatment of endothelial dysfunction and atherogenesis [13].